发明授权
US4446315A Adenosine 5'-triphosphate-4-carboxamide-ribofuranosylthiazole
失效
腺苷5'-三磷酸-4-甲酰胺 - 呋喃核糖基噻唑
- 专利标题： Adenosine 5'-triphosphate-4-carboxamide-ribofuranosylthiazole
- 专利标题（中）： 腺苷5'-三磷酸-4-甲酰胺 - 呋喃核糖基噻唑
-
申请号： US423241申请日： 1982-09-24
-
公开(公告)号： US4446315A公开(公告)日： 1984-05-01
- 发明人: Victor E. Marquez , David A. Cooney , Gulilat Gebeyehu , Hiremagalur N. Jayaram
- 申请人： Victor E. Marquez , David A. Cooney , Gulilat Gebeyehu , Hiremagalur N. Jayaram
- 申请人地址： DC Washington
- 专利权人： The United States of America as represented by the Department of Health and Human Services
- 当前专利权人： The United States of America as represented by the Department of Health and Human Services
- 当前专利权人地址： DC Washington
- 主分类号： C07H19/207
- IPC分类号： C07H19/207 ; C07H19/20
摘要：
The present invention relates to the preparation of and the antitumor compound, adenosine 5'-(trihydrogen diphosphate) 5'.fwdarw.5'-ester with 4-carboxamide-2-.beta.-D-ribofuranosylthiazole.
信息查询
IPC分类:
